The global multiplex assays market is expected to reach $6.24 billion by 2030, driven by the preference for multiplex assays over singleplex varieties and…
Browsing: Oncology
This Perspective discusses the challenges and potential solutions for creating equitable AI models in oncology, including sources of bias and successful examples. It also…
Envisagenics, an AI-driven biotechnology company, has announced a Series B fundraising round with participation from existing and new investors. The funding will be used…
Envisagenics, an AI-driven biotechnology company, has announced a Series B fundraising round with participation from existing and new investors. The funding will be used…
This article discusses the growth and advancements of PET/CT imaging in the field of nuclear medicine. It highlights the role of new radiotracers and…
This article discusses the use and limitations of artificial intelligence (AI) in precision medicine for oncology research and treatment. It highlights the benefits of…
Artificial Intelligence (AI) is increasingly being used in oncology, with applications ranging from cancer diagnostics to radiology and pathology. AI-associated devices have been approved…
Artificial intelligence (AI) is a type of computer science that develops software programs for intelligent execution of tasks or decision making. AI has demonstrated…
Dr. David Agus is a professor of medicine and biomedical engineering and the founding director and CEO of the Ellison Institute of Technology. He…
Artificial intelligence (AI), big data, and machine learning are playing an increasingly important role in the field of oncology. AI can improve disease diagnosis,…